# Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities

> **NCT04487743** · PHASE3 · UNKNOWN · sponsor: **Xiangya Hospital of Central South University** · enrollment: 300 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04487743
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-09
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487743, "Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04487743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*